CClinicalTrials.gg
CompletedNCT01549873Updated Feb 26, 2015Results posted

Anesthesia During Neurophysiologic Monitoring in Scoliosis Patients

An interventional study of propofol and Desflurane in Idiopathic Scoliosis, sponsored by Nationwide Children's Hospital. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2015-02-26.

Sponsored by Nationwide Children's Hospital · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Sex
All
01

Study summary

When patients have spinal surgery, electrodes are placed on the body to measure motor evoked potentials (MEP) and somatosensory evoked potentials (SSEP). Many hospitals only use IV anesthesia because they feel that measuring MEP and SSEP is easier using IV anesthesia. At this hospital the investigators typically use inhaled anesthesia and are able to successfully measure MEP and SSEP. This is a study to find out if one method of anesthesia is better than the other for measuring MEP and SSEP.

02

Conditions studied

  • Idiopathic Scoliosis

Browse trials for

03

In context

Scoliosis

594 studies on the registry are indexed under Scoliosis; 138 are open to participants now.

This study's enrollment of 30 is below the median of 44 across 344 interventional studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

Nationwide Children's Hospital is the lead sponsor of 231 studies on the registry; 43 are open to participants now.

Of its 16 completed or terminated interventional studies of FDA-regulated products, 8 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with idiopathic scoliosis.

Exclusion criteria

Exclusion Criteria:

  • Patients with neuromuscular scoliosis.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Total intravenous anesthesia (TIVA)

    Drug: propofol

  • Active comparator
    Inhaled anesthesia

    Drug: Desflurane

Interventions

  • Drugpropofol

    Propofol adjusted to maintain the bispectral index at 40-60.

    Also known as: Diprivan

  • DrugDesflurane

    Desflurane adjusted to maintain the bispectral index at 40-60.

    Also known as: Suprane

06

What researchers measure

Primary outcomes

  1. Amplitude Required to Elicit the MEP

    Compare the data obtained from neuromonitoring including the amplitude required to elicit the MEP from patients receiving general anesthesia with an inhalational anesthetic agent to those receiving total intravenous anesthesia (TIVA).

    Time frame: at time of surgery

Secondary outcomes

  1. Amplitude of the SSEPs

    SSEPs (somatosensory evoked potentials) are most commonly elicited by bipolar transcutaneous electrical stimulation applied on the skin over the trajectory of peripheral nerves of the upper limb (e.g., the median nerve) or lower limb (e.g., the posterior tibial nerve), and then recorded from the scalp. The amplitude is the voltage of the electrical stimulation recorded.

    Time frame: day of surgery

  2. Latency of the SSEP's

    SSEPs (somatosensory evoked potentials) are most commonly elicited by bipolar transcutaneous electrical stimulation applied on the skin over the trajectory of peripheral nerves of the upper limb (e.g., the median nerve) or lower limb (e.g., the posterior tibial nerve), and then recorded from the scalp. Latency is the time interval between the stimulation and response.

    Time frame: day of surgery

07

Results

Posted Feb 26, 2015

Participant flow

Participant flow — Overall Study
MilestoneTotal Intravenous Anesthesia (TIVA)Inhaled Anesthesia
Started1515
Completed1514
Not completed01
Withdrew: Physician decision01

Outcome measures

PrimaryAmplitude Required to Elicit the MEP

Compare the data obtained from neuromonitoring including the amplitude required to elicit the MEP from patients receiving general anesthesia with an inhalational anesthetic agent to those receiving total intravenous anesthesia (TIVA).

Time frame:
at time of surgery
Reported as:
Mean · milliamperes
Amplitude Required to Elicit the MEP
milliamperesTotal Intravenous Anesthesia (TIVA)Inhaled Anesthesia
Amplitude Required to Elicit the MEP307 ± 72417 ± 82
SecondaryAmplitude of the SSEPs

SSEPs (somatosensory evoked potentials) are most commonly elicited by bipolar transcutaneous electrical stimulation applied on the skin over the trajectory of peripheral nerves of the upper limb (e.g., the median nerve) or lower limb (e.g., the posterior tibial nerve), and then recorded from the scalp. The amplitude is the voltage of the electrical stimulation recorded.

Time frame:
day of surgery
Reported as:
Mean · microvolt
Amplitude of the SSEPs
microvoltTotal Intravenous Anesthesia (TIVA)Inhaled Anesthesia
Amplitude of the SSEPs0.83 ± 0.40.84 ± 0.25
SecondaryLatency of the SSEP's

SSEPs (somatosensory evoked potentials) are most commonly elicited by bipolar transcutaneous electrical stimulation applied on the skin over the trajectory of peripheral nerves of the upper limb (e.g., the median nerve) or lower limb (e.g., the posterior tibial nerve), and then recorded from the scalp. Latency is the time interval between the stimulation and response.

Time frame:
day of surgery
Reported as:
Mean · milliseconds
Latency of the SSEP's
millisecondsTotal Intravenous Anesthesia (TIVA)Inhaled Anesthesia
Latency of the SSEP's27.6 ± 1.928.2 ± 2

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Total Intravenous Anesthesia (TIVA)—0/15 (0%)0/15 (0%)
Inhaled Anesthesia—0/15 (0%)0/15 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Total Intravenous Anesthesia (TIVA)Inhaled AnesthesiaTotal
<=18 years141327
Between 18 and 65 years123
>=65 years000
Age, Continuous
Age, Continuous(years)Total Intravenous Anesthesia (TIVA)Inhaled AnesthesiaTotal
Mean14.5 ± 2.115.4 ± 2.414.9 ± 2.2
Sex: Female, Male
Sex: Female, Male(Participants)Total Intravenous Anesthesia (TIVA)Inhaled AnesthesiaTotal
Female141428
Male112
Region of Enrollment
Region of Enrollment(participants)Total Intravenous Anesthesia (TIVA)Inhaled AnesthesiaTotal
United States151530
08

Study locations

1 site
  • Nationwide Children's Hospital
    Columbus, Ohio 43205, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01549873
Lead sponsor
Nationwide Children's Hospital
Responsible party
Joseph D. Tobias (Chairman, Dept. of Anesthesiology & Pain Medicine, Nationwide Children's Hospital) — Principal investigator
First posted
Mar 9, 2012
Start date
Jan 2012
Primary completion
Apr 2013
Completion
Jun 2013
Results posted
Feb 26, 2015
Last update
Feb 26, 2015

Study contacts

Joseph D Tobias, MD
principal investigator · Nationwide Children's Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion